Oncotelic
Agoura Hills · Founded 1988
About Oncotelic
Oncotelic is an immuno-oncology company developing RNA therapeutics and small molecule drugs against cancer and infectious diseases. It seeks to leverage its deep expertise in drug development to improve treatment outcomes and the survival of cancer patients emphasizing rare pediatric cancers.
Company Facts
- Founded: 1988
- Legal name: Oncotelic Inc.
- Operating status: IPO
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.5M
- Funding stage: IPO
- Last round: Series Unknown (Mar 2010)
- Website: oncotelic.com
- Phone: +1-650-635-7000
Social Profiles
Canonical: https://fsome.com/organization/oncotelic-8326489 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.